Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

iRhythm Technologies reported strong Q4 2024 results, driven by expanding Zio adoption and operational improvements. The company remains focused on FDA remediation and international expansion ...

Learn more about whether Glaukos Corporation or iRhythm Technologies, Inc. is a better investment based on AAII's A+ Investor ...

Zio AT also performed very well throughout 2024, but we saw particular strength during the fourth quarter as there was disruption for our competitor in the marketplace. iRhythm has historically ...

iRhythm Technologies ... primary care settings where Zio's value as a population health management tool has resonated strongly. Throughout 2024, we enhanced our quality systems, improved customer ...